Comprehensive Review of Squamous Cell Carcinoma: Pathophysiology, Clinical Manifestations, Diagnostic Techniques, and Treatment Modalities

Article Sidebar

PDF
Published: Oct 22, 2024
DOI: https://doi.org/10.47191/ijmscrs/v4-i10-30
Keywords:
Squamous Cell Carcinoma, Skin Cancer, Molecular Profiling

Main Article Content

Irisdey Espinoza Urzua
Universidad Nacional Autónoma de Mexico, Facultad de Medicina Ciudad Universitaria. Ciudad de México, México.
Ilse Kritzel González Estudillo
Hospital Dr. Fernando Quiroz. Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado. Ciudad de México, México.

Abstract

Squamous cell carcinoma (SCC) is a prevalent form of skin cancer arising from the squamous cells of the epidermis. This malignancy primarily affects areas of the body exposed to ultraviolet radiation, but it can also develop in mucosal regions and internal organs. The pathophysiology of SCC involves a complex interplay between genetic mutations, environmental factors, and immune system dysregulation. Clinically, SCC presents with varied manifestations, ranging from indolent, well-differentiated lesions to aggressive, invasive tumors. Diagnostic techniques encompass a range of modalities, including dermoscopy, histopathological examination, and molecular profiling. Treatment strategies for SCC are multifaceted, involving surgical excision, radiation therapy, and emerging immunotherapies. This article aims to provide a detailed overview of SCC, focusing on its pathogenesis, clinical features, diagnostic approaches, and therapeutic options, highlighting recent advancements and ongoing research in the field.

Article Details

How to Cite
Irisdey Espinoza Urzua, & Ilse Kritzel González Estudillo. (2024). Comprehensive Review of Squamous Cell Carcinoma: Pathophysiology, Clinical Manifestations, Diagnostic Techniques, and Treatment Modalities. International Journal of Medical Science and Clinical Research Studies, 4(10), 1890–1895. https://doi.org/10.47191/ijmscrs/v4-i10-30
Issue
Vol. 4 No. 10 (2024): Volume 04 Issue 10 October 2024
Section
Articles
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

References

I. Stern RS. Prevalence of a history of skin cancer in 2007: results of an inci- dence-based model. Arch Dermatol 2010; 146:279-82.

II. Rogers HW, Weinstock MA, Feldman SR, Coldiron BM. Incidence estimate of nonmelanoma skin cancer (keratinocyte carcinomas) in the U.S. population, 2012. JAMA Dermatol 2015;151:1081-6.

III. Karia PS, Han J, Schmults CD. Cuta- neous squamous cell carcinoma: estimat- ed incidence of disease, nodal metastasis, and deaths from disease in the United States, 2012. J Am Acad Dermatol 2013; 68:957-66.

IV. Brougham NDLS, Dennett ER, Cam- eron R, Tan ST. The incidence of metasta- sis from cutaneous squamous cell carci- noma and the impact of its risk factors. J Surg Oncol 2012;106:811-5.

V. Mourouzis C, Boynton A, Grant J, et al. Cutaneous head and neck SCCs and risk of nodal metastasis — UK experience. J Craniomaxillofac Surg 2009;37:443-7.

VI. Joseph MG, Zulueta WP, Kennedy PJ. Squamous cell carcinoma of the skin of the trunk and limbs: the incidence of me- tastases and their outcome. Aust N Z J Surg 1992;62:697-701.

VII. Tokez S, Wakkee M, Kan W, et al. Cu- mulative incidence and disease-specific survival of metastatic cutaneous squa- mous cell carcinoma: a nationwide cancer registry study. J Am Acad Dermatol 2022; 86:331-8.

VIII. Garrett GL, Blanc PD, Boscardin J, et al. Incidence of and risk factors for skin cancer in organ transplant recipients in the United States. JAMA Dermatol 2017; 153:296-303.

IX. Genders RE, Weijns ME, Dekkers OM, Plasmeijer EI. Metastasis of cutaneous squamous cell carcinoma in organ trans- plant recipients and the immunocompe- tent population: is there a difference? a systematic review and meta-analysis. J Eur Acad Dermatol Venereol 2019;33: 828-41.

X. Clayman GL, Lee JJ, Holsinger FC, et al. Mortality risk from squamous cell skin cancer. J Clin Oncol 2005;23:759-65.

Robsahm TE, Helsing P, Veierød MB. Cutaneous squamous cell carcinoma in Norway 1963–2011: increasing incidence and stable mortality. Cancer Med 2015;4: 472-80.

XI. Tokez S, Hollestein L, Louwman M, Nijsten T, Wakkee M. Incidence of multi- ple vs first cutaneous squamous cell car- cinoma on a nationwide scale and estima-

XII. tion of future incidences of cutaneous squamous cell carcinoma. JAMA Derma- tol 2020;156:1300-6.

Muzic JG, Schmitt AR, Wright AC, et al. Incidence and trends of basal cell carci- noma and cutaneous squamous cell car- cinoma: a population-based study in Olmsted County, Minnesota, 2000 to 2010. Mayo Clin Proc 2017;92:890-8.

XIII. Kosmadaki MG, Gilchrest BA. The de- mographics of aging in the United States: implications for dermatology. Arch Der- matol 2002;138:1427-8.

XIV. Stang A, Khil L, Kajüter H, et al. Inci- dence and mortality for cutaneous squa- mous cell carcinoma: comparison across three continents. J Eur Acad Dermatol Venereol 2019;33:Suppl 8:6-10.

XV. Gray DT, Suman VJ, Su WP, Clay RP, Harmsen WS, Roenigk RK. Trends in the population-based incidence of squamous cell carcinoma of the skin first diagnosed between 1984 and 1992. Arch Dermatol 1997;133:735-40.

XVI. Higgins S, Nazemi A, Chow M, Wysong A. Review of nonmelanoma skin cancer in African Americans, Hispanics, and Asians. Dermatol Surg 2018;44:903- 10.

XVII. Gloster HM Jr, Neal K. Skin cancer in skin of color. J Am Acad Dermatol 2006; 55:741-60.

Armstrong BK, Kricker A. The epide- miology of UV induced skin cancer. J Pho- tochem Photobiol B 2001;63:8-18.

XVIII. 20. Stern RS; PUVA Follow-Up Study. The risk of squamous cell and basal cell can- cer associated with psoralen and ultravio- let A therapy: a 30-year prospective study. J Am Acad Dermatol 2012;66:553-62.

XIX. 21. Wehner MR, Shive ML, Chren M-M, Han J, Qureshi AA, Linos E. Indoor tan- ning and non-melanoma skin cancer: sys- tematic review and meta-analysis. BMJ 2012;345:e5909.